Andrew Bellinger, CSO & CMO at Verve Therapeutics, Inc. (VERV), sold 865 shares at $22.95 ($20K) on 2022-12-01, disclosed to the SEC on 2022-12-02.
Open-market sale of $20k VERV by CSO & CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VERV | SELL | 2022-07-22 | $698K | — | Filing → |
| VERV | SELL | 2022-07-15 | $249K | — | Filing → |
| VERV | SELL | 2021-12-27 | $1.2M | — | Filing → |